JPRN-UMIN000012194Completed未知
Safety cofirmatory study for Percutaneous cryoablation of vascular malformations - SCIRO-1303 study
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Okayama University Hospital
- Enrollment
- 9
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 13years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Under 13 years old. 2) Patients have severe comorbidities as follows: a. Uncontroled malignant tumor. b. Serious lung disease. c. Serious heart trouble. d. Serious liver disease. e. Severe active inflammation and infectious disease. f. Poor control diabetes. g. Immunocompromised state including the whole steroid therapy. h. Case having complications considered to disturb completion of the cryoablation. 4) Past history of radiation exposure to the lesion. 5) Probe insertion can't be performed safely. 6) Clinical clear bleeding tendency (PT-INR >=1.5) 7) Drugs such as antiplatelet agent, anticoagulant, thrombolytic agent can't be ceased temporarily. 8) Being pregnant or may be pregnant. 9) Considered unsuitable for being enrolled in this clinical trial by a attending physician.
Investigators
Similar Trials
Completed
Phase 2
Safety and Clinical Outcomes of Percutaneous Cryoablation for Musculoskeletal Tumor: a Phase-II Clinical Studymusculoskeletal tumorJPRN-UMIN000009906Department of Radiology, Mie University School of Medicine20
Active, not recruiting
Phase 2
Evaluation of safety and effectiveness of cryoablation in the treatment of TSC-AMrenal angiomyolipoma associated with tuberous sclerosisJPRN-jRCTs072200039Eto Masatoshi15
Recruiting
Not Applicable
Study of the ClariFix Cryoablation Device in Patients with Chronic Rhinitis - New ZealandChronic rhinitisRespiratory - Other respiratory disorders / diseasesACTRN12614000468628Arrinex, Inc.30
Completed
Phase 2
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
Recruiting
Phase 2
Radioation therapy followed by cryoablation for malignant lung tumorsJPRN-UMIN000037215Kashiwa Kousei General Hospital, Thoracic Surgery200